Patient-Friendly Explanation
Venous thromboembolism (VTE) is a condition where dangerous blood clots form in your deep veins, usually in the legs. If a clot breaks loose, it can travel to your lungs — a life-threatening emergency called a pulmonary embolism. People with obesity have a much higher risk of developing these clots because excess body fat increases inflammation, slows blood flow, and makes the blood more prone to clotting.
Clinical Definition
VTE encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). Obesity increases VTE risk 2- to 3-fold through multiple mechanisms: adipose tissue secretes plasminogen activator inhibitor-1 (PAI-1), which impairs fibrinolysis; chronic low-grade inflammation elevates pro-coagulant factors (fibrinogen, factors VII and VIII); venous stasis from increased intra-abdominal pressure reduces blood flow velocity in the lower extremities; and obesity is associated with platelet hyperreactivity. The risk is compounded by obesity-related comorbidities including immobility, joint disease, and the need for surgery.
Why It Matters
Weight loss is one of the most effective strategies to reduce VTE risk, as it lowers PAI-1 levels, reduces inflammatory markers, and improves venous return. At NuLifeCare Singapore, our weight management programme includes VTE risk assessment and prevention education as part of a comprehensive approach to metabolic and vascular health.